BRIEF-Medirom Healthcare Technologies Entered Into A MOU For Purpose Of Acquiring All Shares Of Stock Of Japan Gene Medicine Corporation-February 2024-www.financetom.com

BRIEF-Medirom Healthcare Technologies Entered Into A MOU For Purpose Of Acquiring All Shares Of Stock Of Japan Gene Medicine Corporation

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Medirom Healthcare Technologies Entered Into A MOU For Purpose Of Acquiring All Shares Of Stock Of Japan Gene Medicine Corporation

Apr 2, 2024 2:02 PM

April 2 (Reuters) - Medirom Healthcare Technologies Inc ( MRM )

* MEDIROM HEALTHCARE TECHNOLOGIES INC ( MRM ) - ENTERED INTO A MOU

FOR

PURPOSE OF ACQUIRING ALL SHARES OF STOCK OF JAPAN GENE MEDICINE

CORPORATION

* MEDIROM HEALTHCARE TECHNOLOGIES INC ( MRM ) - PROPOSED DEAL FOR

TOTAL

PRICE OF 2.4 BILLION YEN

Source text for Eikon:

Further company coverage:

Previous page： Copa Holdings Passenger Traffic Climbs in May Next page： --West Fraser Timber Ups Quarterly Dividend by $0.02 to $0.32 a Share, Payable July 12 to Shareholders of Record June 26

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Copa Holdings Passenger Traffic Climbs in May

Jun 12, 2024

05:34 PM EDT, 06/12/2024 (MT Newswires) -- Copa Holdings ( CPA ) said Wednesday its May preliminary passenger traffic, measured as revenue passenger miles, rose by 8.7% from a year earlier. Preliminary statistics also showed its capacity, measured as available seat miles, increased by 7.2%, the company said. The system load factor was 87.3%, up 1.2 percentage points, Copa added....

--West Fraser Timber Ups Quarterly Dividend by $0.02 to $0.32 a Share, Payable July 12 to Shareholders of Record June 26

Jun 12, 2024

05:32 PM EDT, 06/12/2024 (MT Newswires) -- Price: 79.14, Change: +0.08, Percent Change: +0.10 ...

Pfizer Prospective Treatment for Duchenne Muscular Dystrophy Fails to Meet Goals

Jun 12, 2024

05:30 PM EDT, 06/12/2024 (MT Newswires) -- Pfizer ( PFE ) late Wednesday said a late-stage trial of its fordadistrogene movaparvovec candidate in young boys with Duchenne Muscular Dystrophy did not meet the primary and secondary endpoints. The trial sought to compare fordadistrogene movaparvovec with placebo in boys aged four to seven years with Duchenne, one year after the treatment...

Okta Insider Sold Shares Worth $1,645,987, According to a Recent SEC Filing

Jun 12, 2024

05:31 PM EDT, 06/12/2024 (MT Newswires) -- Jacques Frederic Kerrest, Director, on June 10, 2024, sold 18,878 shares in Okta ( OKTA ) for $1,645,987. SEC Filing: https://www.sec.gov/Archives/edgar/data/1660134/000166013424000090/xslF345X03/wk-form4_1718227532.xml Price: 88.50, Change: -0.79, Percent Change: -0.88 ...